{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:55:39Z","timestamp":1773788139101,"version":"3.50.1"},"reference-count":38,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[1999,7,1]],"date-time":"1999-07-01T00:00:00Z","timestamp":930787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[1999,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Mechanisms of resistance to azoles in\n            <jats:italic>Candida albicans<\/jats:italic>\n            , the main etiologic agent of oropharyngeal candidiasis (OPC), include alterations in the target enzyme (lanosterol demethylase) and increased efflux of drug. Previous studies on mechanisms of resistance have been limited by the fact that only a single isolate from each OPC episode was available for study. Multiple isolates from each OPC episode were evaluated with oral samples plated in CHROMagar Candida with and without fluconazole to maximize detection of resistant yeasts. A total of 101 isolates from each of three serial episodes of OPC from four different patients were evaluated. Decreasing geometric means of fluconazole MICs with serial episodes of infection were detected in the four patients. However, 8-fold or larger (up to 32-fold) differences in fluconazole MICs were detected within isolates recovered at the same time point in 7 of 12 episodes. Strain identity was analyzed by DNA typing techniques and indicated that isolates from each patient represented mainly isogenic strains, but differed among patients. A Northern blot technique was used to monitor expression of\n            <jats:italic>ERG11<\/jats:italic>\n            (encoding lanosterol demethylase) and genes coding for efflux pumps. This analysis revealed that clinical isolates obtained from the same patient and episode were phenotypically heterogeneous in their patterns of expression of these genes involved in fluconazole resistance. These results demonstrate the complexity of the distribution of the molecular mechanisms of antifungal drug resistance and indicate that different subpopulations of yeasts may coexist at a given time in the same patient and may develop resistance through different mechanisms.\n          <\/jats:p>","DOI":"10.1128\/aac.43.7.1621","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T00:35:16Z","timestamp":1539045316000},"page":"1621-1630","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":76,"title":["Multiple Resistant Phenotypes of\n            <i>Candida albicans<\/i>\n            Coexist during Episodes of Oropharyngeal Candidiasis in Human Immunodeficiency Virus-Infected Patients"],"prefix":"10.1128","volume":"43","author":[{"given":"Jose L.","family":"Lopez-Ribot","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Departments of Medicine1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert K.","family":"McAtee","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Departments of Medicine1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Perea","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Departments of Medicine1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Kirkpatrick","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Departments of Medicine1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Rinaldi","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Pathology,2 The University of Texas Health Science Center at San Antonio, and"},{"name":"<!--label omitted: 3-->South Texas Veterans Health Care System, Audie L. Murphy Division,3 San Antonio, Texas 78284"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas F.","family":"Patterson","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Departments of Medicine1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.12.2835"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0030-4220(94)90148-1","article-title":"Immunological aspects of candidiasis.","volume":"78","author":"Challacombe S. J.","year":"1994","unstructured":"Challacombe S. J. Immunological aspects of candidiasis. Med. Oral Pathol. 78 1994 202 210","journal-title":"Med. Oral Pathol."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00259685"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.12.3065"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.11.2938"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198408093110602"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/34.5.659"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.33.6.1501-1509.1995"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1097(97)00172-9"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.11.2932"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.62.1.71-109.1998"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01964058"},{"key":"e_1_3_2_14_2","unstructured":"National Committee for Clinical Laboratory Standards\n          Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard. NCCLS document M27-A.\n          1997\n          National Committee for Clinical Laboratory Standards\n          Wayne Pa"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.34.12.3237-3239.1996"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.34.7.1794-1797.1996"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/clinids\/24.5.776","article-title":"Antifungal susceptibility testing: technical advances and potential clinical implications.","volume":"24","author":"Pfaller M. A.","year":"1997","unstructured":"Pfaller M. A. Rex J. H. Rinaldi M. G. Antifungal susceptibility testing: technical advances and potential clinical implications. Clin. Infect. Dis. 24 1997 776 784","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/myc.1990.33.9-10.421","article-title":"Oral candidosis in HIV-infected patients. Prognostic value and correlation with immunological parameters.","volume":"33","author":"Plettenberg A.","year":"1990","unstructured":"Plettenberg A. Reisinger E. Lenzner U. Listemann H. Ernst M. Kern P. Dietrich M. Meigel W. Oral candidosis in HIV-infected patients. Prognostic value and correlation with immunological parameters. Mycoses 33 1990 421 425","journal-title":"Mycoses"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1994.10.925"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00352101"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.4.821"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0002-9343(98)00137-5","article-title":"A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in human immunodeficiency virus-infected patients: clinical outcomes and development of fluconazole resistance.","volume":"105","author":"Revankar S. G.","year":"1998","unstructured":"Revankar S. G. Kirkpatrick W. R. McAtee R. K. Dib O. P. Fothergill A. W. Redding S. W. Rinaldi M. G. Patterson T. F. A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in human immunodeficiency virus-infected patients: clinical outcomes and development of fluconazole resistance. Am. J. Med. 105 1998 7 10","journal-title":"Am. J. Med."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.2.235"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.1.1"},{"key":"e_1_3_2_25_2","unstructured":"Sambrook\n              J. F.\n              Fritsch\n              E. F.\n              Maniatis\n              T.\n          Molecular cloning: a laboratory manual\n          2nd ed.\n          1989\n          Cold Spring Harbor Laboratory Press\n          Cold Spring Harbor N.Y"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.2.241"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.10.2300"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-143-2-405"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.11.2378"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.28.6.1236-1243.1990"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.8.1625"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(98)93162-0"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0966-842X(94)90618-1"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1042\/bst0180056","article-title":"Mutation in cytocrome P450-dependent 14\u03b1 demethylase results in decreased affinity for azole antifungals.","volume":"18","author":"Vanden Bossche H.","year":"1990","unstructured":"Vanden Bossche H. Marichal P. Gorrens J. Bellens D. Moereels H. Janssen P. A. J. Mutation in cytocrome P450-dependent 14\u03b1 demethylase results in decreased affinity for azole antifungals. Biochem. Soc. Trans. 18 1990 56 59","journal-title":"Biochem. Soc. Trans."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1080\/02681219780001021"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.7.1482"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.7.1488"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.11.2.382"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.1997.tb00336.x"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.43.7.1621","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.43.7.1621","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T16:25:22Z","timestamp":1645460722000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.43.7.1621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1999,7]]}},"alternative-id":["10.1128\/AAC.43.7.1621"],"URL":"https:\/\/doi.org\/10.1128\/aac.43.7.1621","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,7]]},"assertion":[{"value":"1999-02-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-05-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}